About New York Consortium (New York Univ. and Columbia Univ.)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at New York Consortium (New York Univ. and Columbia Univ.)
During the past decade, New York Consortium (New York Univ. and Columbia Univ.) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "New York Consortium (New York Univ. and Columbia Univ.)"
#1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at New York Consortium (New York Univ. and Columbia Univ.)
According to Clinical.Site data, the most researched conditions in "New York Consortium (New York Univ. and Columbia Univ.)" are
"Asthma" (2 trials). Many other conditions were trialed in "New York Consortium (New York Univ. and Columbia Univ.)" in a lesser frequency.
Clinical Trials Intervention Types at New York Consortium (New York Univ. and Columbia Univ.)
Most popular intervention types in "New York Consortium (New York Univ. and Columbia Univ.)" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Education" (1 trials), "Fluticasone plus salmeterol" (1 trials), "Montelukast" (1 trials), "fluticasone" (1 trials) and "montelukast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at New York Consortium (New York Univ. and Columbia Univ.)
The vast majority of trials in "New York Consortium (New York Univ. and Columbia Univ.)" are
2 trials for "All" genders.
Clinical Trials Status at New York Consortium (New York Univ. and Columbia Univ.)
Currently, there are NaN active trials in "New York Consortium (New York Univ. and Columbia Univ.)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in New York Consortium (New York Univ. and Columbia Univ.),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in New York Consortium (New York Univ. and Columbia Univ.), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".